JABLX vs. JNGLX
JABLX (Janus Henderson VIT Balanced Portfolio) and JNGLX (Janus Henderson Global Life Sciences Fund) are both mutual funds - JABLX is a Diversified Portfolio fund managed by Janus Henderson, while JNGLX is a Health & Biotech Equities fund managed by Janus Henderson. Over the past 10 years, JABLX returned 10.50%/yr vs 10.41%/yr for JNGLX. A 0.72 correlation means they provide meaningful diversification when combined. JABLX charges 0.62%/yr vs 0.80%/yr for JNGLX.
Performance
JABLX vs. JNGLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JABLX achieves a 3.38% return, which is significantly higher than JNGLX's -2.51% return. Both investments have delivered pretty close results over the past 10 years, with JABLX having a 10.50% annualized return and JNGLX not far behind at 10.41%.
JABLX
- 1D
- -0.55%
- 1M
- 2.16%
- YTD
- 3.38%
- 6M
- 3.50%
- 1Y
- 14.17%
- 3Y*
- 13.91%
- 5Y*
- 7.88%
- 10Y*
- 10.50%
JNGLX
- 1D
- 1.13%
- 1M
- -0.29%
- YTD
- -2.51%
- 6M
- -0.73%
- 1Y
- 26.17%
- 3Y*
- 9.73%
- 5Y*
- 7.15%
- 10Y*
- 10.41%
JABLX vs. JNGLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JABLX Janus Henderson VIT Balanced Portfolio | 3.38% | 15.13% | 15.42% | 15.41% | -16.36% | 17.20% | 14.21% | 22.60% | 0.68% | 18.44% |
JNGLX Janus Henderson Global Life Sciences Fund | -2.51% | 24.84% | 3.60% | 7.51% | -2.69% | 6.78% | 25.66% | 29.20% | 4.17% | 22.13% |
Correlation
The correlation between JABLX and JNGLX is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Jan 5, 1999 | 0.72 |
Over the past year, the correlation between JABLX and JNGLX has dropped to 0.44 - well below their long-term average of 0.72, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JABLX vs. JNGLX — Risk / Return Rank
JABLX
JNGLX
JABLX vs. JNGLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson VIT Balanced Portfolio (JABLX) and Janus Henderson Global Life Sciences Fund (JNGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JABLX | JNGLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | -0.19 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.31 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.82 | 2.75 | -0.94 |
| Martin ratioReturn relative to average drawdown | 7.85 | 8.75 | -0.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| JABLX | JNGLX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.69 | 1.79 | -0.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.71 | 0.45 | +0.26 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.95 | 0.60 | +0.35 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.93 | 0.57 | +0.36 |
Drawdowns
JABLX vs. JNGLX - Drawdown Comparison
The maximum JABLX drawdown since its inception was -27.07%, smaller than the maximum JNGLX drawdown of -59.00%. Use the drawdown chart below to compare losses from any high point for JABLX and JNGLX.
Loading charts...
Drawdown Indicators
| JABLX | JNGLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.07% | -59.00% | +31.93% |
Max Drawdown (1Y)Largest decline over 1 year | -8.10% | -9.68% | +1.58% |
Max Drawdown (3Y)Largest decline over 3 years | -11.89% | -21.17% | +9.28% |
Max Drawdown (5Y)Largest decline over 5 years | -21.30% | -22.21% | +0.91% |
Max Drawdown (10Y)Largest decline over 10 years | -22.47% | -27.37% | +4.90% |
Current DrawdownCurrent decline from peak | -0.55% | -5.44% | +4.89% |
Average DrawdownAverage peak-to-trough decline | -4.71% | -17.65% | +12.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.87% | 3.04% | -1.17% |
Volatility
JABLX vs. JNGLX - Volatility Comparison
The current volatility for Janus Henderson VIT Balanced Portfolio (JABLX) is 2.52%, while Janus Henderson Global Life Sciences Fund (JNGLX) has a volatility of 4.80%. This indicates that JABLX experiences smaller price fluctuations and is considered to be less risky than JNGLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JABLX | JNGLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.52% | 4.80% | -2.28% |
Volatility (6M)Calculated over the trailing 6-month period | 6.93% | 10.89% | -3.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 8.74% | 14.86% | -6.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 11.16% | 15.86% | -4.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 11.11% | 17.38% | -6.27% |
JABLX vs. JNGLX - Expense Ratio Comparison
JABLX has a 0.62% expense ratio, which is lower than JNGLX's 0.80% expense ratio.
Dividends
JABLX vs. JNGLX - Dividend Comparison
JABLX's dividend yield for the trailing twelve months is around 4.99%, more than JNGLX's 4.68% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JABLX Janus Henderson VIT Balanced Portfolio | 4.99% | 5.16% | 2.02% | 2.01% | 4.78% | 1.58% | 3.14% | 4.43% | 5.22% | 1.71% | 3.64% | 5.22% |
JNGLX Janus Henderson Global Life Sciences Fund | 4.68% | 4.56% | 5.84% | 4.26% | 0.25% | 9.85% | 7.80% | 6.23% | 13.32% | 0.89% | 0.30% | 8.81% |
Frequently Asked Questions
JABLX and JNGLX have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JNGLX has higher volatility (4.80%) compared to JABLX (2.52%). In terms of maximum drawdown, JABLX dropped -27.07% vs JNGLX's -59.00%.
JNGLX currently has the higher Sharpe Ratio (1.79 vs 1.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JABLX and JNGLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer